Find Delapril Hydrochloride manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Delapril hcl, 83435-67-0, Adecut, Rev 6000a, Cv 3317, Rev-6000a
Molecular Formula
C26H33ClN2O5
Molecular Weight
489.0  g/mol
InChI Key
FDJCVHVKXFIEPJ-JCNFZFLDSA-N
FDA UNII
2SMM3M5ZMH

Delapril Hydrochloride
Delapril Hydrochloride is the hydrochloride salt of delapril, a lipophilic, non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, delapril is converted to two active metabolites, delapril diacid and 5-hydroxy delapril diacid, which competitively bind to and inhibit ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II and results in vasodilation. Delapril also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex, which leads to an increase in sodium excretion and subsequently increases water outflow.
1 2D Structure

Delapril Hydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[2,3-dihydro-1H-inden-2-yl-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]amino]acetic acid;hydrochloride
2.1.2 InChI
InChI=1S/C26H32N2O5.ClH/c1-3-33-26(32)23(14-13-19-9-5-4-6-10-19)27-18(2)25(31)28(17-24(29)30)22-15-20-11-7-8-12-21(20)16-22;/h4-12,18,22-23,27H,3,13-17H2,1-2H3,(H,29,30);1H/t18-,23-;/m0./s1
2.1.3 InChI Key
FDJCVHVKXFIEPJ-JCNFZFLDSA-N
2.1.4 Canonical SMILES
CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N(CC(=O)O)C2CC3=CC=CC=C3C2.Cl
2.1.5 Isomeric SMILES
CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N(CC(=O)O)C2CC3=CC=CC=C3C2.Cl
2.2 Other Identifiers
2.2.1 UNII
2SMM3M5ZMH
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Cv 3317

2. Cv-3317

3. Delapril

4. Derapril

5. N-(2,3-dihydro-1h-inden-2-yl)-n-(n-(1-(ethoxycarbonyl)-3-phenylpropyl)alanyl)glycine

2.3.2 Depositor-Supplied Synonyms

1. Delapril Hcl

2. 83435-67-0

3. Adecut

4. Rev 6000a

5. Cv 3317

6. Rev-6000a

7. 2smm3m5zmh

8. Cv-3317

9. Ethyl (s)-2-(((s)-1-((carboxymethyl)-2-indanylcarbamoyl)ethyl)amino)-4-phenylbutyrate, Monohydrochloride

10. Delapril (hydrochloride)

11. 2-[2,3-dihydro-1h-inden-2-yl-[(2s)-2-[[(2s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]amino]acetic Acid;hydrochloride

12. Glycine, N-(2,3-dihydro-1h-inden-2-yl)-n-(n-(1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl)-, Monohydrochloride, (s)-

13. Indalapril

14. 2-((s)-n-(2,3-dihydro-1h-inden-2-yl)-2-(((s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanamido)acetic Acid Hydrochloride

15. 2-[(2s)-n-(2,3-dihydro-1h-inden-2-yl)-2-{[(2s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanamido]acetic Acid Hydrochloride

16. Ccris 1925

17. Delapril Hydrochloride [usan:jan]

18. Ncgc00181755-01

19. Unii-2smm3m5zmh

20. Cupressin

21. Delaket

22. Adecut (tn)

23. Delapril?hydrochloride

24. Alindapril Hydrochloride

25. Dsstox_cid_28523

26. Dsstox_rid_82795

27. N-(n-((s)-1-ethoxycarbonyl-3-phenylpropyl)-l-alanyl)-n-(indan-2-yl)glycine Hydrochloride

28. Dsstox_gsid_48597

29. Glycine, N-((1s)-1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl-n-(2,3-dihydro-1h-inden-2-yl)-, Monohydrochloride

30. Schembl120907

31. Chembl2106126

32. Dtxsid6048597

33. Chebi:31462

34. Delapril Hydrochloride [mi]

35. Delapril Hydrochloride (jan/usan)

36. Delapril Hydrochloride [jan]

37. Tox21_112927

38. Delapril Hydrochloride [usan]

39. Mfcd00884619

40. S5728

41. Akos015915580

42. Delapril Hydrochloride [mart.]

43. Ccg-269602

44. Delapril Hydrochloride [who-dd]

45. As-15996

46. Cas-83435-67-0

47. Hy-107337

48. Cs-0028174

49. D4082

50. D01667

51. Q27255552

52. N-[1-(s)-ethoxycarbonyl-3-phenylpropyl]-(s)-alanyl-n-(2-indanyl)glycine Hydrochloride

53. N-[1-(s)-ethoxycarbonyl-3-phenylpropyl]-l-alanyl-n-(indan-2-yl)glycine Hydrochloride

54. 2-((s)-n-(2,3-dihydro-1h-inden-2-yl)-2-((s)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanamido)acetic Acid Hydrochloride

55. Glycine,n-[(1s)-1-(ethoxycarbonyl)-3-phenylpropyl]-l-alanyl-n-(2,3-dihydro-1h-inden-2-yl)-, Monohydrochloride

56. N-[(s)-1-ethoxycarbonyl-3-phenylpropyl]-l-alanyl-n-(2,3-dihydroinden-2-yl)glycine Hydrochloride

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 489.0 g/mol
Molecular Formula C26H33ClN2O5
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count6
Rotatable Bond Count12
Exact Mass488.2077999 g/mol
Monoisotopic Mass488.2077999 g/mol
Topological Polar Surface Area95.9 Ų
Heavy Atom Count34
Formal Charge0
Complexity649
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Angiotensin-Converting Enzyme Inhibitors

A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)


Antihypertensive Agents

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)


API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1630434600,"product":"DELAPRIL HYDROCHLORIDE","address":"206, ERIC HOUSE, 16TH ROAD,CHEMBUR,","city":"MUMBAI, MAHARASHTRA.","supplier":"PIONEER AGRO EXTRACTS","supplierCountry":"INDIA","foreign_port":"KIEV","customer":"VITAMINY","customerCountry":"UKRAINE","quantity":"12.00","actualQuantity":"12","unit":"KGS","unitRateFc":"2000","totalValueFC":"27625","currency":"EUR","unitRateINR":169333.33333333334,"date":"01-Sep-2021","totalValueINR":"2032000","totalValueInUsd":"27625","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"4290803","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"UKRAINE","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"206, ERIC HOUSE, 16TH ROAD,CHEMBUR,, MUMBAI, MAHARASHTRA.","customerAddress":""}]
01-Sep-2021
01-Sep-2021
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Delapril Hydrochloride Manufacturers

A Delapril Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Delapril Hydrochloride, including repackagers and relabelers. The FDA regulates Delapril Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Delapril Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Delapril Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Delapril Hydrochloride Suppliers

A Delapril Hydrochloride supplier is an individual or a company that provides Delapril Hydrochloride active pharmaceutical ingredient (API) or Delapril Hydrochloride finished formulations upon request. The Delapril Hydrochloride suppliers may include Delapril Hydrochloride API manufacturers, exporters, distributors and traders.

click here to find a list of Delapril Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Delapril Hydrochloride JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Delapril Hydrochloride Drug Master File in Japan (Delapril Hydrochloride JDMF) empowers Delapril Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Delapril Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Delapril Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Delapril Hydrochloride suppliers with JDMF on PharmaCompass.

Delapril Hydrochloride WC

A Delapril Hydrochloride written confirmation (Delapril Hydrochloride WC) is an official document issued by a regulatory agency to a Delapril Hydrochloride manufacturer, verifying that the manufacturing facility of a Delapril Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Delapril Hydrochloride APIs or Delapril Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Delapril Hydrochloride WC (written confirmation) as part of the regulatory process.

click here to find a list of Delapril Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.

Delapril Hydrochloride GMP

Delapril Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Delapril Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Delapril Hydrochloride GMP manufacturer or Delapril Hydrochloride GMP API supplier for your needs.

Delapril Hydrochloride CoA

A Delapril Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Delapril Hydrochloride's compliance with Delapril Hydrochloride specifications and serves as a tool for batch-level quality control.

Delapril Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Delapril Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Delapril Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Delapril Hydrochloride EP), Delapril Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Delapril Hydrochloride USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty